Oracle Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Oracle Corporation on December 20, 2021. The report discloses a material corporate event under Item 8.01 (Other Events) regarding a proposed acquisition of Cerner Corporation.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for Oracle or Cerner. The document focuses exclusively on the terms of the proposed merger agreement.
Material Changes and Transaction Details
On December 20, 2021, Oracle and Cerner entered into an Agreement and Plan of Merger. The key terms of the transaction are:
- Acquisition Method: A cash tender offer followed by a merger.
- Purchase Price: $95.00 per share of Cerner common stock, payable in cash.
- Structure: Oracle will utilize a wholly-owned subsidiary (Merger Subsidiary) to acquire all outstanding shares of Cerner. Upon completion, the Merger Subsidiary will merge into Cerner, which will become a wholly-owned subsidiary of Oracle.
- Status: The tender offer has not yet commenced at the time of this filing.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance or management commentary on future performance. It notes that the tender offer is subject to terms and conditions and that the transaction is not yet complete. Investors are directed to future filings (Schedule TO and Schedule 14D-9) for detailed risk factors and material information regarding the offer.
Key Facts for Investor Verification
- Verify the final approval status of the merger by Cerner's board and shareholders.
- Monitor the commencement of the tender offer and the filing of Schedule TO materials with the SEC.
- Confirm the total transaction value based on the outstanding share count of Cerner at the time of the offer.
- Review future regulatory filings for any conditions precedent that could delay or terminate the agreement.